EcoR1 Capital’s Kite Pharma, Inc. KITE Stock Holding History

EcoR1 Capital’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150,000	Closed	-$6.89M	–	43
2016 Q1	$6.89M	Sell	150,000 -16,000	-10%	-$775K	2.41%	18
2015 Q4	$10.2M	Sell	166,000 -115,400	-41%	-$8.12M	3.21%	13
2015 Q3	$15.7M	Hold	281,400	–	–	7.13%	7
2015 Q2	$17.2M	Hold	281,400	–	–	5.72%	6
2015 Q1	$16.2M	Sell	281,400 -157,000	-36%	-$10.5M	5.41%	8
2014 Q4	$25.3M	Buy	+438,400	New	+$18.5M	12.79%	1

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EcoR1 Capital's KITE Position: Q2 2016 in Review

EcoR1 Capital sold out of Kite Pharma, Inc. (KITE) in Q2 2016, closing a stake of 150,000 shares — an estimated $6.89M sold.

EcoR1 Capital first reported a position in KITE in Q4 2014 and held it in 6 quarters. The position peaked at $25.3M in Q4 2014. 173 funds tracked by Wall St. Rank hold KITE as of Q2 2016.

EcoR1 Capital reported no remaining Kite Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
EcoR1 Capital sold 150,000 Kite Pharma, Inc. shares in Q2 2016, an estimated $6.89M.
EcoR1 Capital first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 6 quarters.
EcoR1 Capital's Kite Pharma, Inc. position peaked at $25.3M in Q4 2014.
173 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2016.

Based on EcoR1 Capital's 13F filing for Q2 2016, filed 15 Aug 2016.